SYSTEM: ONLINE
UTC
V5.0.1
MISSION_REPORT /// HEALTHCARE

Operation Medusa: Securing Intellectual Property in Biotech

Client / Partner
Astra-Zenon Biotherapeutics
Timeline
December 2025
Sector
Healthcare
Status
DEPLOYED_SUCCESS

Intelligence Briefing

In late 2025, Astra-Zenon Biotherapeutics detected a series of sophisticated LinkedIn-based social engineering attempts targeting senior researchers in their oncology division.

The Attack Vector

The campaign utilized Cognitive Security bypass techniques, creating synthetic personas that perfectly mimicked academic peers to solicit "feedback" on sensitive R&D documents.

SOVRINT Deployment

SOVRINT's Social Engineering Defense identified the linguistic fingerprints of the synthetic personas. By cross-referencing with Threat Actor Profiling, we attributed the campaign to a known state-sponsored group within 72 hours.

Results

  • Zero data breach incidents.
  • 24 identified spear-phishing accounts neutralized.
  • Complete mapping of the actor's exfiltration infrastructure.
$850M
IP Value Secured
24
Spear-Phish Detected
92%
Actor Attribution

Solutions Deployed.

The following SOVRINT solutions were utilized in this mission theater:

Evidence ID
SOV-INT-2025-ALPHA-09-VALID
Intelligence report fully validated via SOVRINT Evidence Integrity.
Procurement Path

Start A Secure
Evaluation.

Built for agencies, governments, and regulated teams that need clear onboarding, evidence integrity, and deployment options from cloud to sovereign environments.

Request Evaluation Access

Security documentation, deployment diagrams, and governance materials are available during evaluation for qualified institutional teams.

How Engagement Works

Structured Evaluation Workflow
Step 01

Security And Mission Scoping

Align mission goals, data boundaries, and procurement constraints.

Step 02

Evaluation Environment

Provision a controlled evaluation aligned to your deployment model.

Step 03

Deployment Decision

Finalize architecture, support model, and onboarding timeline.